ALS Limited secures full ownership of Nuvisan Pharma
SYDNEY, AUSTRALIA: ALS Limited (ASX: ALQ) has announced the acquisition of the remaining 51% stake in Nuvisan Pharma Holding GmbH, a leading European contract research organization (CRO). The acquisition, which includes Nuvisan GmbH and Innovation Campus Berlin (ICB), comes at…